Albemarle (NYSE:ALB) Reaches New 1-Year High Following Analyst Upgrade

Key Points

• Shares hit a new 52‑week high after Mizuho raised its price target to $205 (from $185) while keeping a Neutral rating; multiple brokers also lifted targets and the MarketBeat consensus target is $183.83 with 13 Buys, 12 Holds and 2 Sells.
• Q1 results beat expectations — EPS $2.95 vs. $1.24 expected and revenue $1.43B (up ~32.7% YoY) driven by stronger lithium pricing and volumes, though the company still reported a negative net margin.
• Insider and shareholder actions: CEO J. Kent Masters sold 11,783 shares (an ~8.05% reduction in his holdings), and the board declared a quarterly dividend of $0.405/share (annualized $1.62, ~0.8% yield).

Albemarle Corporation (NYSE:ALB - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Friday after Mizuho raised their price target on the stock from $185.00 to $205.00. Mizuho currently has a neutral rating on the stock. Albemarle traded as high as $221.00 and last traded at $198.3190, with a volume of 4287859 shares. The stock had previously closed at $192.61.

A number of other research firms also recently weighed in on ALB. Jefferies Financial Group lifted their price target on shares of Albemarle from $210.00 to $230.00 and gave the stock a "buy" rating in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Albemarle from $185.00 to $195.00 and gave the stock a "buy" rating in a research note on Tuesday, February 17th. JPMorgan Chase & Co. decreased their price target on shares of Albemarle from $195.00 to $145.00 and set a "neutral" rating on the stock in a research note on Friday, February 13th. Evercore lifted their price target on shares of Albemarle from $100.00 to $180.00 in a research note on Wednesday, February 18th. Finally, Berenberg Bank set a $153.00 price target on shares of Albemarle in a research note on Monday, February 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $183.83.

Insider Activity

In other Albemarle news, CEO J Kent Masters sold 11,783 shares of Albemarle stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $170.81, for a total transaction of $2,012,654.23. Following the completion of the transaction, the chief executive officer directly owned 134,628 shares of the company's stock, valued at approximately $22,995,808.68. This trade represents a 8.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.42% of the company's stock.

More Albemarle News

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Q1 results beat expectations — Albemarle reported $2.95 EPS vs. $1.24 expected and revenue of $1.43B (up ~32.7% YoY), driven by stronger pricing and volumes. This outsized beat is the primary catalyst for the stock move today. ALB Tops Q1 Earnings and Revenue Estimates
• Positive Sentiment: Management noted strong lithium pricing and higher volumes that lifted Energy Storage sales ~70%, supporting near-term margin and cash-flow improvements tied to EV battery demand. Lithium pricing and volumes lift results
• Positive Sentiment: Conference call and slide deck provide supporting detail on segment performance and volumes that investors can use to validate sustainability of the beat. Q1 Earnings Call Transcript
• Neutral Sentiment: FY‑2026 revenue guidance was published roughly in line with consensus (~$5.7B–$6.0B reported), so while near-term results surprised positively, full‑year expectations imply limited incremental upside unless pricing/volume trends continue. PR News Release (Q1 Results)
• Neutral Sentiment: Mizuho raised its price target from $185 to $205 but kept a Neutral rating, signaling cautious optimism — the new PT implies only modest upside from current levels. Benzinga note
• Negative Sentiment: Despite the beat, Albemarle still reported a negative net margin (~‑10.7%) and a negative P/E on trailing metrics, which raises questions about cost items, one‑offs or non‑operational charges that could temper enthusiasm until margins sustainably improve. MarketBeat earnings summary
• Positive Sentiment: Board declared a quarterly dividend of $0.405/share (annualized $1.62) — small yield but signals shareholder returns continuity. Dividend announcement

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in ALB. Strategic Advocates LLC bought a new position in shares of Albemarle during the third quarter valued at $25,000. MH & Associates Securities Management Corp ADV bought a new position in shares of Albemarle during the fourth quarter valued at $26,000. BOKF NA lifted its holdings in shares of Albemarle by 5,771.4% during the third quarter. BOKF NA now owns 411 shares of the specialty chemicals company's stock valued at $33,000 after acquiring an additional 404 shares during the period. Cromwell Holdings LLC lifted its holdings in shares of Albemarle by 36.8% during the third quarter. Cromwell Holdings LLC now owns 413 shares of the specialty chemicals company's stock valued at $34,000 after acquiring an additional 111 shares during the period. Finally, Elyxium Wealth LLC bought a new position in shares of Albemarle during the fourth quarter valued at $34,000. 92.87% of the stock is owned by institutional investors.

Albemarle Price Performance

The stock has a fifty day moving average of $179.56 and a 200-day moving average of $154.41. The company has a quick ratio of 1.57, a current ratio of 2.23 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $23.38 billion, a P/E ratio of -58.16, a PEG ratio of 1.38 and a beta of 1.36.

Albemarle (NYSE:ALB - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The specialty chemicals company reported $2.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $1.71. Albemarle had a positive return on equity of 5.20% and a negative net margin of 5.00%.The business had revenue of $1.43 billion during the quarter, compared to analysts' expectations of $1.34 billion. During the same period in the previous year, the business posted ($0.18) earnings per share. The firm's revenue for the quarter was up 32.7% compared to the same quarter last year. Equities analysts predict that Albemarle Corporation will post 8.72 EPS for the current fiscal year.

Albemarle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Friday, June 12th will be issued a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 12th. Albemarle's payout ratio is currently -28.17%.

About Albemarle

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company's bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world's foremost chemical producers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.